Bharat Biotech’s Covaxin for Children Aged 2-18 Under Evaluation: Govt Sources
An expert panel of the Central Drugs Standard Control Organisation (CDSCO) recommended granting emergency use authorization (EUA) for Bharat Biotech manufactured Covaxin for those aged 2 to 18.